Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Vallon

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
Acta Physiologica (Oxford, England)|June 8, 2023
Did you know how SGLT2 inhibitors protect the kidney?Anita T Layton, Volker Vallon
Annual Review of Physiology|February 17, 2012
Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidneyVolker Vallon, Scott C Thomson
Physiology (Bethesda, Md.)|April 11, 2019
How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?Hadi Fattah, Anita Layton, Volker Vallon
Current Hypertension Reports|March 8, 2005
The salt paradox and its possible implications in managing hypertensive diabetic patientsVolker Vallon, Roland Blantz, Scott Thomson
Expert Opinion on Therapeutic Targets|September 22, 2009
Targeting SGK1 in diabetesFlorian Lang, Agnes Görlach, Volker Vallon
European Journal of Heart Failure|February 5, 2008
Adenosine and kidney function: potential implications in patients with heart failureVolker Vallon, Cindy Miracle, Scott Thomson
Diabetes/Metabolism Research and Reviews|January 19, 2017
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectivesHongyu Qiu, Aleksandra Novikov, Volker Vallon
Physiological Reviews|July 4, 2006
Adenosine and kidney functionVolker Vallon, Bernd Mühlbauer, Hartmut Osswald
European Journal of Pharmacology|November 28, 2006
Adenosine A1 receptors determine effects of caffeine on total fluid intake but not caffeine appetiteTimo Rieg, Jürgen Schnermann, Volker Vallon
Current Opinion in Nephrology and Hypertension|July 9, 2009
The physiological impact of the serum and glucocorticoid-inducible kinase SGK1Florian Lang, Ferruh Artunc, Volker Vallon
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Acta Physiologica (Oxford, England)|June 8, 2023
Did you know how SGLT2 inhibitors protect the kidney?Anita T Layton, Volker Vallon
Annual Review of Physiology|February 17, 2012
Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidneyVolker Vallon, Scott C Thomson
Physiology (Bethesda, Md.)|April 11, 2019
How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?Hadi Fattah, Anita Layton, Volker Vallon
Current Hypertension Reports|March 8, 2005
The salt paradox and its possible implications in managing hypertensive diabetic patientsVolker Vallon, Roland Blantz, Scott Thomson
Expert Opinion on Therapeutic Targets|September 22, 2009
Targeting SGK1 in diabetesFlorian Lang, Agnes Görlach, Volker Vallon
European Journal of Heart Failure|February 5, 2008
Adenosine and kidney function: potential implications in patients with heart failureVolker Vallon, Cindy Miracle, Scott Thomson
Diabetes/Metabolism Research and Reviews|January 19, 2017
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectivesHongyu Qiu, Aleksandra Novikov, Volker Vallon
Physiological Reviews|July 4, 2006
Adenosine and kidney functionVolker Vallon, Bernd Mühlbauer, Hartmut Osswald
European Journal of Pharmacology|November 28, 2006
Adenosine A1 receptors determine effects of caffeine on total fluid intake but not caffeine appetiteTimo Rieg, Jürgen Schnermann, Volker Vallon
Current Opinion in Nephrology and Hypertension|July 9, 2009
The physiological impact of the serum and glucocorticoid-inducible kinase SGK1Florian Lang, Ferruh Artunc, Volker Vallon
Pageof 21